Epidermal growth factor and serum activate distinct pathways to inhibit the BH3 only protein BAD in prostate

O S P Chao1, M-V Clément

  • 1Department of Biochemistry, Faculty of Medicine, National University of Singapore, Singapore.

Oncogene
|June 13, 2006
PubMed

Insights

Understanding prostate cancer cell survival pathways is crucial for targeted therapies. Epidermal growth factor and serum inhibit cell death by affecting BAD and BAX protein translocation, independent of phosphatidylinositol 3-kinase signaling.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Signaling

Background:

  • Understanding prostate cancer cell survival mechanisms is key to developing targeted therapies.
  • Phosphatidylinositol 3-kinase (PI3K) inhibitors like LY294002 induce apoptosis in LNCaP cells, but this is counteracted by serum or epidermal growth factor (EGF).
  • The intracellular pathways mediating this survival signaling remain poorly defined.

Purpose of the Study:

  • To investigate the mechanisms by which serum or EGF inhibit LY294002-induced apoptosis in LNCaP prostate cancer cells.
  • To elucidate the role of BAD and BAX protein translocation and phosphorylation in PI3K-independent survival pathways.

Main Methods:

  • Cell death was quantified by sub-G1 phase analysis and caspase 3 activity assays.
  • Protein phosphorylation and translocation were assessed using Western blotting for BAD, ERK1/2, and RSKs.
  • Gene knockdown of BAD, BAX, RSK1, and RSK2 was performed via siRNA transfection.

Main Results:

  • LY294002-induced cell death involves the mitochondrial translocation of BAD and BAX proteins.
  • EGF activates the MAPK/ERK/RSK1 pathway, leading to BAD phosphorylation at Ser75 and its inactivation.
  • Serum promotes survival by creating an intracellular environment that inhibits the mitochondrial translocation of dephosphorylated BAD.

Conclusions:

  • Phosphorylation of BAD or inhibition of its mitochondrial translocation are critical PI3K-independent survival pathways in LNCaP cells.
  • These findings highlight novel therapeutic targets for overcoming resistance to PI3K-targeted therapies in prostate cancer.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...